An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against ...
An early-stage clinical trial of an experimental Ebola vaccine conducted at the National Institutes of Health (NIH) and the Walter Reed Army Institute of Research (WRAIR) found that the vaccine, called VSV-ZEBOV, ...
The Ebola virus is not mutating as quickly as scientists had feared, which is good news for treating the disease and preventing its spread, a study showed Thursday.
An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus.
A cytomegalovirus (CMV)-based vaccine provides long-lasting protective immunity against Ebola virus, and has potential for development as a disseminating vaccine strategy to prevent ebolavirus infection of ...
The Ebola outbreak that has swept West Africa since 2014 may have cleared the way for a more familiar killer that could claim thousands of more lives—measles.
In the ongoing Ebola outbreak in West Africa, whose death toll is approaching 10,000, little information has been available about how the human immune response unfolds after infection.
It took 16 years of twists and turns. Over and over, Dr. Nancy Sullivan thought she was close to an Ebola vaccine, only to see the next experiment fail.
Insect-eating bats that inhabited a hollow tree in a remote village in Guinea may have been the source of the world's biggest Ebola epidemic, scientists said on Tuesday.
German doctors on Friday gave details of how an experimental drug together with advanced intensive care helped save a Ugandan physician who had been airlifted from Sierra Leone with Ebola.
Traces of Ebola have been found in the semen of a man six months after his recovery, the World Health Organization said Wednesday, urging survivors to practice safe sex "until further notice".
Research from The University of Manchester using cutting edge computer analysis reveals that despite mutating, Ebola hasn't evolved to become deadlier since the first outbreak 40 years ago.
Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check attendant.
A Japanese research team said Thursday it had developed a field test for Ebola that gives results in just over 11 minutes—down from the 90-minute test used now.